key: cord-0810033-6dyitx6x authors: Freeman, Karoline; Geppert, Julia; Stinton, Chris; Todkill, Daniel; Johnson, Samantha; Clarke, Aileen; Taylor-Phillips, Sian title: Use of artificial intelligence for image analysis in breast cancer screening programmes: systematic review of test accuracy date: 2021-09-02 journal: BMJ DOI: 10.1136/bmj.n1872 sha: aefd8ffb5ee8a98f40c5f71c4dd5aeb5bc61a6d7 doc_id: 810033 cord_uid: 6dyitx6x OBJECTIVE: To examine the accuracy of artificial intelligence (AI) for the detection of breast cancer in mammography screening practice. DESIGN: Systematic review of test accuracy studies. DATA SOURCES: Medline, Embase, Web of Science, and Cochrane Database of Systematic Reviews from 1 January 2010 to 17 May 2021. ELIGIBILITY CRITERIA: Studies reporting test accuracy of AI algorithms, alone or in combination with radiologists, to detect cancer in women’s digital mammograms in screening practice, or in test sets. Reference standard was biopsy with histology or follow-up (for screen negative women). Outcomes included test accuracy and cancer type detected. STUDY SELECTION AND SYNTHESIS: Two reviewers independently assessed articles for inclusion and assessed the methodological quality of included studies using the QUality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool. A single reviewer extracted data, which were checked by a second reviewer. Narrative data synthesis was performed. RESULTS: Twelve studies totalling 131 822 screened women were included. No prospective studies measuring test accuracy of AI in screening practice were found. Studies were of poor methodological quality. Three retrospective studies compared AI systems with the clinical decisions of the original radiologist, including 79 910 women, of whom 1878 had screen detected cancer or interval cancer within 12 months of screening. Thirty four (94%) of 36 AI systems evaluated in these studies were less accurate than a single radiologist, and all were less accurate than consensus of two or more radiologists. Five smaller studies (1086 women, 520 cancers) at high risk of bias and low generalisability to the clinical context reported that all five evaluated AI systems (as standalone to replace radiologist or as a reader aid) were more accurate than a single radiologist reading a test set in the laboratory. In three studies, AI used for triage screened out 53%, 45%, and 50% of women at low risk but also 10%, 4%, and 0% of cancers detected by radiologists. CONCLUSIONS: Current evidence for AI does not yet allow judgement of its accuracy in breast cancer screening programmes, and it is unclear where on the clinical pathway AI might be of most benefit. AI systems are not sufficiently specific to replace radiologist double reading in screening programmes. Promising results in smaller studies are not replicated in larger studies. Prospective studies are required to measure the effect of AI in clinical practice. Such studies will require clear stopping rules to ensure that AI does not reduce programme specificity. STUDY REGISTRATION: Protocol registered as PROSPERO CRD42020213590. (false NEAR/4 (negativ* or positiv*)):ti,ab,kw #37 (true NEAR/4 (positiv* or negativ*)):ti,ab,kw #38 (liklihood ratio*):ti,ab,kw #39 ((predict* or test*) NEAR/1 (value* or accura* or error*)):ti,ab,kw #40 MeSH descriptor: [Reproducibility of Results] explode all trees #41 #25 or #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35 or #36 or #37 or #38 or #39 or #40 #42 #24 and #41 For test set studies, this translates as has the test set been clearly described as an external (geographically) validation set? No -Any internal validation (e.g. split sample, crossvalidation) or temporal validation Unclear -No details stated about the training set and tuning set Yes -External geographical validation (Test set was sample from a different centre; can be in another country or the same country) For prospective applied studies in a clinical context: Yes -If the study is located at different centre(s) to those who provided mammograms used to train and tune the AI algorithm Unclear -If not stated No -If there is any overlap Is there concern that the included patients do not match the review question? High -If 'yes' for any of the following statements Unclear -If no details are provided Low -If 'no' for all the following statements • Not a consecutive or random sample of women attending screening; • Enriched sample / cancer prevalence doesn't match screening context (>3%); • Mammograms not from full-field digital mammography; • Mammograms not from screening (e.g. diagnostic or symptomatic) or only subset such as recalled cases or false-negatives included (cancer might be easier or more difficult to detect); • Women/women's mammograms not representative of UK population (ethnicity, age) Were the index test results interpreted without knowledge of the results of the reference standard? For index tests where a human is involved (either human read comparator, AI as reader aid, or included otherwise on the AI testing pathway, e.g. arbitration): Yes -Require clear statement of blinding, or clear temporal relationships where the human read occurred before the reference standard No -Otherwise For index test where AI is used without any human element: Yes -AI system has not previously been trained on these mammograms or learned from these mammograms or other mammograms from the same women No -If any repeat use of the same cases then (unless explicit that the AI algorithm was pre-set and did not change upon repeat use, and the study did not select one of several AI systems based on use with the same cases) Unclear -If not explicit that there has been no repeat within same or previous studies Were the index test results interpreted without knowledge of the results of any other index tests? No -If human readers were not blinded to AI (unless that AI is specifically part of the same index test) No -If AI systems are trained or calibrated using decisions from human readers in same cases Yes -Otherwise If a threshold was used, was it prespecified? Yes -If using a commercially available AI system which gives a yes/no result, or threshold clearly pre-specified in methods Yes -For systems giving a risk score and study explicitly states the pre-specified threshold No -Using sensitivity / specificity of the reader as benchmark using the same dataset No -Setting the threshold with the validation set without temporal evidence (e.g. published protocol) that threshold was truly pre-specified NA -Human readers or human/AI combinations Where human readers are part of the test, were their decisions made in a clinical practice context? (i.e. avoidance of the laboratory effect) Yes -If the readers made decisions in the clinical context, and those decisions were used to decide whether to recall women (either prospectively as part of a trial or test accuracy study or retrospective studies using the original decision) No -If readers examined a test set (of any prevalence) outside clinical practice, or any other context likely to result in the laboratory effect 1 Is there concern that the index test(s) or comparator, its conduct, or interpretation differ from the review question? High -If 'yes' for any of the following Unclear -If no details are provided Low -If 'no' for all of the following • AI system not yet commercially available, e.g. in house systems; • Study did not use a pre-specified threshold for AI system; • Not a complete testing pathway applicable to clinical practice (for example AI accuracy for single read, but not integrated into screening centre decisions, e.g. arbitration); No -If there was significant (>10%) loss to follow up for reference standards of interval cancers or subsequent screening results No -If any women who should have received a biopsy or follow-up tests after index test positive results did not receive one or results were unavailable Yes -otherwise Did the study avoid choosing which reference standard based on results of just one of the index tests? (All studies will necessarily have differential verification, because not all women can or should be biopsied. Here we are measuring whether deciding which reference standard is received based on results of just one of the index tests is avoided.) Yes -For test-treat RCTs randomizing to different test strategies and their associated recall decisions Yes -If women testing positive in any of the included index tests (AI pathways or comparator human pathways) all receive follow up tests/biopsy in a prospective study No -If women were recalled for further tests on the basis of one of the index tests, and not other(s) then this will cause bias because cancer, when present, is more likely to be found if the person receives follow-up tests after recall from screening No -In retrospective studies, the decision whether to recall for follow-up tests/biopsy was made on the basis of the human readers' decision. We do not know whether AI positive, human reader negative women are false positive or true positive, and what type of true positive. Follow-up to development of interval cancers will detect some, but not all of these cancers, so reduces, but does not eliminate this bias No -For prospective studies where decision to recall is informed by one index test but not all, or is more influenced by one index test than others Unclear -Retrospective reader studies (enriched test set studies) in which readers prospectively read retrospective data, the reference standard is not based on any index test but the reference standard is based on the original human reader decision. The reviewers are unclear about the risk of bias. Were all patients included in the analysis? Yes -If there were any exclusions after the point of selecting the cohort, for example intermediate or indeterminate results Population -Subpopulation: Studies only including images with cancer. These are not sufficient to estimate test accuracy of AI for screening mammograms, as it excludes specificity, and the trade-off between sensitivity and specificity. Studies on images of subpopulations by screening risk or screening outcome. They do not represent the screening population and no inference on the performance of the AI system in a screening population can be drawn (however, subpopulations by ethnicity or socioeconomic status are included as the impact of any change on equity is important). This does not apply to populations which represent a group of women at any stage within the screening pathway (e.g. recalled women without selection on final diagnosis) on the assumption that AI could be incorporated for this subgroup only. Population -<90% screening mammograms or unclear proportion: Studies on images of diagnostic mammograms, with >10% diagnostic mammograms or an unclear proportion of diagnostic mammograms. These do not represent the use case in the screening context. Internal validation -Cross validation, Leave-one out, Split sample: Studies using internal validation whereby the validation dataset used to assess a model uses data which were used to develop that model. Cross validation and leave-one out are resampling techniques which use the original data to assist with preliminary assessment and fine-tuning of the model during validation. The issue of using data on which an algorithm was trained with is that models can be prone to overfitting; whereby the model fits the trained data extremely well, but to the detriment of the model's ability to perform when presented with new data, which is known as poor generalization. The split-sample approach is generally an inefficient form of internal validation because it does not accurately reflect a model's generalisability. Intervention -Detecting subtypes: Studies using AI to detect cancer subtypes such as microcalcifications or architectural distortions only. The detection of cancer subtypes does not present the complete picture of cancer detection (e.g. microcalcifications are associated mainly with DCIS and not with cancer; detecting microcalcifications only will miss some types of cancers). On their own, these AI systems do not provide the information on cancer present/ not present to inform a decision whether to recall or not recall. Systems reporting single features could be combined to provide a more complete picture, however, studies would need to report an overall outcome of test accuracy of the combination of systems. Intervention -No detection/classification: Studies using AI for lesion enhancement or segmentation of pectoral muscle regions. These studies do not report on the classification of images into recall or no recall and are uninformative in terms of test performance of AI. Intervention -Not AI: Studies using traditional computer aided detection without machine learning features for the detection of lesions in images. In AI the layers of features are not designed by human expertise; instead they are learnt from the underlying data. Therefore, studies reporting the test accuracy and effectiveness of traditional CAD systems were considered significantly different from studies assessing machine learning AI systems. Intervention -Prediction of cancer: Studies using AI for the prediction of future cancer risk including the detection of breast density and parenchymal patterns as risk factors. These studies did not consider the detection of cancer present on screening mammograms. No relevant outcomes: Studies reporting accuracy without outcomes characterising the trade-off between false positive and false negative results including global measures such as the area under the curve (AUC). The trade-off between false positive and false negative results is critical to test accuracy. Study type -Systematic reviews with no relevant outcomes: Studies reporting systematic reviews that were off topic and did not provide additional references for the review. Document Supply cancelled request: no location found: Studies unavailable following internet searches, contacting authors and pursuing interlibrary requests. The "laboratory" effect: comparing radiologists' performance and variability during prospective clinical and laboratory mammography interpretations A Computerized System for Detection of Spiculated Margins based on Mammography Population -Image type Classification of Mammogram Images Using Multiscale all Convolutional Neural Network (MA-CNN) A dual stage adaptive thresholding (DuSAT) for automatic mass detection in mammograms Population -Image type Focal breast lesion characterization according to the BI-RADS US lexicon: role of a computer-aided decision-making support Population -Image type An efficient fractal method for detection and diagnosis of breast masses in mammograms Population -Image type Computer-Aided Detection of Mammographic Masses Using Hybrid Region Growing Controlled by Multilevel Thresholding Population -Image type Analysis of different types of entropy measures for breast cancer diagnosis using ensemble classification Reference Main reason for exclusion An Efficient Segmentation and Classification System in Medical Images Using Intuitionist Possibilistic Fuzzy C-Mean Clustering and Fuzzy SVM Algorithm Analog Computer-Aided Detection (CAD) information can be more effective than binary marks Detecting masses in dense breast using independent component analysis Population -Image type Computer-aided detection of breast cancer on mammograms: a swarm intelligence optimized wavelet neural network approach Population -Image type Breast cancer risk assessment and diagnosis model using fuzzy support vector machine based expert system Population -Image type An improved decision support system for detection of lesions in mammograms using Differential Evolution Optimized Wavelet Neural Network Population -Image type Analysis of k-means clustering approach on the breast cancer Wisconsin dataset Population -Image type Novel approach to classification of Abnormalities in the mammogram image Population -Image type Computer-aided model for breast cancer detection in mammograms Population -Image type Anomaly classification in digital mammography based on multiple-instance learning Breast cancer diagnosis in digital mammogram using multiscale curvelet transform Reference Main reason for exclusion Development and validation of a fully automated system for detection and diagnosis of mammographic lesions Bilateral Image Subtraction and Multivariate Models for the Automated Triaging of Screening Mammograms Contralateral asymmetry for breast cancer detection: A CADx approach Computer-aided detection and diagnosis of mammographic masses using multi-resolution analysis of oriented tissue patterns A support vector machine classifier with rough set-based feature selection for breast cancer diagnosis Support vector machine based diagnostic system for breast cancer using swarm intelligence Applying a new quantitative image analysis scheme based on global mammographic features to assist diagnosis of breast cancer A generalized multiple classifier system for improving computer-aided classification of breast masses in mammography Combining multiple feature representations and AdaBoost ensemble learning for reducing false-positive detections in computer-aided detection of masses on mammograms Computer-aided detection (CAD) of breast masses in mammography: combined detection and ensemble classification Reference Main reason for exclusion Automated breast image classification using features from its discrete cosine transform A computer-aided diagnosis scheme of breast lesion classification using GLGLM and shape features: Combined-view and multiclassifiers Breast mass classification on mammograms using radial local ternary patterns Discovering mammography-based machine learning classifiers for breast cancer diagnosis Effect of pixel resolution on texture features of breast masses in mammograms Computerized detection of breast tissue asymmetry depicted on bilateral mammograms: a preliminary study of breast risk stratification Computer-aided classification of mammographic masses using visually sensitive image features Deep Learning to Distinguish Recalled but Benign Mammography Images in Breast Cancer Screening Predicting Breast Cancer by Applying Deep Learning to Linked Health Records and Mammograms A CNN based method for automatic mass detection and classification in mammograms Reference Main reason for exclusion Preliminary evaluation of differentiation of benign and malignant breast tumors using non-invasive diagnostic modalities Grid infrastructures for developing mammography CAD systems Fusion of k-Gabor features from medio-lateral-oblique and craniocaudal view mammograms for improved breast cancer diagnosis Breast cancer data classification using machine learning mechanisms Malignancy Detection on Mammography Using Dual Deep Convolutional Neural Networks and Genetically Discovered False Color Input Enhancement Discrimination of A new approach to the detection of lesions in mammography using fuzzy clustering Deep Neural Networks Improve Radiologists' Performance in Breast Cancer Screening A Deep Learning Model to Triage Screening Mammograms: A Simulation Study A novel and reliable computational intelligence system for breast cancer detection Reference Main reason for exclusion Segmentation of Masses on Mammograms Using Data Augmentation and Deep Learning Abnormal breast identification by nine-layer convolutional neural network with parametric rectified linear unit and rank-based stochastic pooling Automated segmentation of malignant mass in mammography using the principal component analysis network based deep learning model Multi-view probabilistic classification of breast microcalcifications Detecting and classifying linear structures in mammograms using random forests A wrapper based binary shuffled frog algorithm for efficient classification of mammograms A New Method for Detecting Architectural Distortion in Mammograms by NonSubsampled Contourlet Transform and Improved PCNN Intervention -Detecting subtypes Usage of case-based reasoning, neural network and adaptive neuro-fuzzy inference system classification techniques in breast cancer dataset classification diagnosis Retrieval boosted computer-aided diagnosis of clustered microcalcifications for breast cancer Characterization of Architectural Distortion in Mammograms Based on Texture Analysis Using Support Vector Machine Classifier with Clinical Evaluation Expert system based on neuro-fuzzy rules for diagnosis breast cancer Identification of mammography anomalies for breast cancer detection by an ensemble of Intervention -Detecting subtypes Reference Main reason for exclusion classification models based on artificial immune system. Knowledge-Based Systems An automated method for detecting architectural distortions on mammograms using direction analysis of linear structures Improving computer-aided detection assistance in breast cancer screening by removal of obviously false-positive findings Reducing false positives of microcalcification detection systems by removal of breast arterial calcifications Intervention -Detecting subtypes Evaluation of breast amorphous calcifications by a computer-aided detection system in full-field digital mammography Intervention -Detecting subtypes Characterizing the Clustered Microcalcifications on Mammograms to Predict the Pathological Classification and Grading: A Mathematical Modeling Approach Texture-based analysis of clustered microcalcifications detected on mammograms Improving the performance of computer-aided detection of subtle breast masses using an adaptive cueing method Intervention -Detecting subtypes Improving performance of computeraided detection of masses by incorporating bilateral mammographic density asymmetry: an assessment Dynamic graph cut based segmentation of mammogram Reference Main reason for exclusion An Automated System for Classification of Radiographs of the Breast Evaluation of a computer-aided detection (CAD)-enhanced 2D synthetic mammogram: comparison with standard synthetic 2D mammograms and conventional 2D digital mammography Reduction of False-Positive Markings on Mammograms: a Retrospective Comparison Study Using an Artificial Intelligence-Based CAD Abnormality detection and classification in computer-aided diagnosis (CAD) of breast cancer images Automatic Pectoral Muscle Region Segmentation in Mammograms Using Genetic Algorithm and Morphological Selection Model based non-rigid registration framework for high dynamic range mammography Single reading with computer-aided detection performed by selected radiologists in a breast cancer screening program Role of computer-aided detection in very small screening detected invasive breast cancers Intervention -Not AI Impact of computeraided detection systems on radiologist accuracy with digital mammography Short-term outcomes of screening mammography using computer-aided detection a population-based study of medicare enrollees Reference Main reason for exclusion Is computer aided detection (CAD) cost effective in screening mammography? A model based on the CADET II study Standalone computer-aided detection compared to radiologists' performance for the detection of mammographic masses Computeraided detection of masses at mammography: interactive decision support versus prompts Intervention -Not AI Who could benefit the most from using a computer-aided detection system in full-field digital mammography Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection Radiologists' perceptions of computer aided detection versus double reading for mammography interpretation Impact on breast cancer diagnosis in a multidisciplinary unit after the incorporation of mammography digitalization and computer-aided detection systems Cost-effectiveness analysis for breast cancer screening: Double reading versus single + CAD reading Intervention -Not AI Computer-aided classification of breast masses: performance and interobserver variability of expert radiologists versus residents Intervention -Not AI Mammography screening using independent double reading with consensus: is there a potential benefit for computer-aided detection? Mammographic Classification Using Stacked Ensemble Learning with Bagging and Boosting Techniques Deep feature-based automatic classification of mammograms Population -Image type A study on breast cancer analysis by using knearest neighbor with different distances and classification rules using machine learning Population -Image type Investigation on performance analysis of support vector machine for classification of abnormal regions in medical image Population -Image type Retrospective comparison between single reading plus an artificial intelligence algorithm and two-view digital tomosynthesis with double reading in breast screening Population -Image type Early detection of breast cancer using hybrid of series network and VGG-16 Population -Image type Observational Study to Evaluate the Clinical Efficacy of Thermalytix for Detecting Breast Cancer in Symptomatic and Asymptomatic Women Population -Image type A computer-aided approach for automatic detection of breast masses in digital mammogram via spectral clustering and support vector machine Reference Main reason for exclusion Diagnosis of breast cancer based on modern mammography using hybrid transfer learning. Multidimensional systems and signal processing 2021:1-19 Population -Image type Early detection of breast malignancy using wavelet features and optimized classifier Population -Image type Automated breast cancer detection using hybrid extreme learning machine classifier Population -Image type Detection and classification of breast cancer from digital mammograms using hybrid extreme learning machine classifier Population -Image type Multi-class Breast Cancer Classification using Ensemble of Pretrained models and Transfer Learning Population -Image type An intelligent healthcare system for optimized breast cancer diagnosis using harmony search and simulated annealing (HS-SA) algorithm Population -Image type A Hybrid Supervised Machine Learning Classifier System for Breast Cancer Prognosis Using Feature Selection and Data Imbalance Handling Approaches Population -Image type A hybrid model using teaching-learning-based optimization and Salp swarm algorithm for feature selection and classification in digital mammography Classification of masses in digital mammograms using Biogeography-based optimization technique Population -Image type Diagnostic Value of Breast Lesions Between Deep Learning-Based Computer-Aided Diagnosis System and Experienced Radiologists: Comparison the Population -Image type Reference Main reason for exclusion Performance Between Symptomatic and Asymptomatic Patients Population -Subpolulation (e.g. only cancer cases) (n=3) Retrospective analysis of the effect on interval cancer rate of adding an artificial intelligence algorithm to the reading process for two-dimensional fullfield digital mammography Population -Subpopulation Can artificial intelligence reduce the interval cancer rate in mammography screening? Population -Subpopulation Application of artificial intelligence-based computer-assisted diagnosis on synthetic mammograms from breast tomosynthesis: comparison with digital mammograms A proposed framework for diagnosis and breast cancer detection Population -<90% screening mammograms or unclear proportion Improving the Prediction of Benign or Malignant Breast Masses Using a Combination of Image Biomarkers and Clinical Parameters Population -<90% screening mammograms or unclear proportion CNN analysis for mammogramdisease detection Population -<90% screening mammograms or unclear proportion Internal validation -Cross validation (n=5) A Comparison of Regions of Interest in Parenchymal Analysis for Breast Cancer Risk Assessment Breast cancer masses classification using deep convolutional neural networks and transfer learning Applying a random projection algorithm to optimize machine learning model for breast lesion classification Effective multiple cancer disease diagnosis frameworks for improved healthcare using machine learning Cross-modality image feature fusion diagnosis in breast cancer Deep learning algorithm for breast masses classification in mammograms Detecting Asymmetric Patterns and Localizing Cancers on Mammograms. Patterns An interpretable classifier for high-resolution breast cancer screening images utilizing weakly supervised localization Internal validation -Split sample Intervention -Detecting subtypes (n=1) 34. Vedalankar AV, Gupta SS, Manthalkar RR. Addressing architectural distortion in mammogram using AlexNet and support vector machine Intervention -Detecting subtypes Outcomes -No relevant outcomes (n=1) 35. Nct. Mammography Screening With Artificial Intelligence (MASAI) 31 No enrichment: Mammograms from Spanish tomosynthesis screening trial Original outcomes: Normal readings (with two-year follow-up): 14,795 (92.5%) FP recalls: 1,078 (6.7%) Screen detected cancers: 98 (0.6%) Going from double to single reading for screening exams labeled as likely normal by AI: what is the impact? Effect of artificial intelligence-based triaging of breast cancer screening mammograms on cancer detection and radiologist workload: a retrospective simulation study Identifying normal mammograms in a large screening population using artificial intelligence Robust breast cancer detection in mammography and digital breast tomosynthesis using an annotation-efficient deep learning approach International evaluation of an AI system for breast cancer screening Improving Breast Cancer Detection Accuracy of Mammography with the Concurrent Use of an Artificial Intelligence Tool AI-based Strategies to Reduce Workload in Breast Cancer Screening with Mammography and Tomosynthesis: A Retrospective Evaluation Detection of Breast Cancer with Mammography: Effect of an Artificial Intelligence Support System Stand-Alone Artificial Intelligence for Breast Cancer Detection in Mammography: Comparison With 101 Radiologists Can radiologists improve their breast cancer detection in mammography when using a deep learning based computer system as decision support External Evaluation of 3 Commercial Artificial Intelligence Algorithms for Independent Assessment of Screening Mammograms Evaluation of Combined Artificial Intelligence and Radiologist Assessment to Interpret Screening Mammograms Improved Cancer Detection Using Artificial Intelligence: a Retrospective Evaluation of Missed Cancers on Mammography 2) Comparison with reader study excluded due to internal validation test set (split sample).3) Simulation study excluded as it is based on test accuracy estimated obtained using internal validation test sets (split sample). Rodriguez-Ruiz 2018 34 Excluded AI as stand-alone reader due to lack of outcomes such as sensitivity and specificity (only AUC).Rodriguez-Ruiz 2019 32 Excluded AI as stand-alone reader due to lack of outcomes such as sensitivity and specificity (only AUC).Rodriguez-Ruiz 2019 33 Excluded data sets A and D-H as <90% screening mammograms or unclear proportion of screening mammograms.Excluded data set B as no relevant outcomes reported. Schaffter 2020 36 Excluded the Kaiser Permanente Washington (KPW) dataset as it was used for training and evaluation (split sample). Lotter 2021 28 The paper reports on 5 test sets; only one data set (Site D) is an external test set of screening FFDMs.Two test sets are excluded as they are also used for training, one test set uses DBT (not FFDM) images, and one test set uses diagnostic (not screening) FFDMs.The study of pre-index cancers was excluded as the analysis included a sub-population of cancers with a negative previous screening result, therefore the analysis was based on images of subpopulations by screening outcome.Raya-Povedano 2021 31 Simulated autonomous AI triaging strategy excluded as simulation study.